- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
A Survived Case of WPW Syndrome, Against Which Continuous Administration of Procainamide Was Effective
-
- Shimizu Keiki
- Tertiary Emergency Medical Center, Saitama Red Cross Hospital
-
- Yokote Ryo
- Tertiary Emergency Medical Center, Saitama Red Cross Hospital
-
- Sekii Hajime
- Tertiary Emergency Medical Center, Saitama Red Cross Hospital
-
- Taguchi Shigemasa
- Tertiary Emergency Medical Center, Saitama Red Cross Hospital
-
- Miyake Yasufumi
- Department of Emergency and Critical Care Medicine, Showa University School of Medicine
-
- Kiyota Kazuya
- Tertiary Emergency Medical Center, Saitama Red Cross Hospital
Bibliographic Information
- Other Title
-
- プロカインアミド持続静注が効果的であったWPW症候群の1蘇生例
Search this article
Description
Case: 54-year-old male. Previous Illnesses: WPW syndrome. Present Illness: The patient suddenly collapsed on a street in cardiopulmonary arrest. As return of spontaneous circulation could be obtained, the patient was transferred to our hospital. Following admission to the ICU, the patient frequently exhibited tachycardial arrhythmia. Cardioversion at 100 J using ECG gating and intravenous injection of pilsicainide were ineffective, and there was no response to disopyramide. Only continuous intravenous infusion of procainamide was effective. Procainamide was subsequently injected initially at 500mg followed by maintaining at 300mg/hr, after which the tachycardia subsided. Blood procainamide concentrations were found to be suitably maintained and there were no adverse side effects observed. After the patient's level of consciousness improved, catheter ablasion was performed at another hospital after which the patient was able to return to society. The recommended approach for the treatment of tachycardia in the Guideline 2000 basically consists of the implementation of cardioversion. In this case, only procainamide was effective, it was administered by continuous intravenous infusion. Continuous intravenous infusion of procainamide may be a possible candidate for such treatment as a kind of bridge until curative treatment.
Journal
-
- Nihon Kyukyu Igakukai Zasshi
-
Nihon Kyukyu Igakukai Zasshi 17 (1), 7-12, 2006
Japanese Association for Acute Medicine
- Tweet
Details 詳細情報について
-
- CRID
- 1390001204371332992
-
- NII Article ID
- 130003626020
- 10018260150
-
- NII Book ID
- AN10284604
-
- ISSN
- 18833772
- 0915924X
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- Crossref
- CiNii Articles
- OpenAIRE
-
- Abstract License Flag
- Disallowed